Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical Oncology.
2014 to 2017 Saw Improvement in Burnout for U.S. Physicians
MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.
National Health Spending Set to Increase 5.5 Percent Annually
FRIDAY, Feb. 22, 2019 (HealthDay News) — National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.
Most Patients Do Not Disclose Complementary Medicine Use
FRIDAY, Feb. 22, 2019 (HealthDay News) — Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.
Guideline Covers Extracutaneous Manifestations of Psoriasis
FRIDAY, Feb. 22, 2019 (HealthDay News) — The extracutaneous manifestations of psoriasis and guidance on use of biologic treatment for management of psoriasis are discussed in two new guidelines published online Feb. 13 in the Journal of the American Academy of Dermatology.
FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy
THURSDAY, Feb. 21, 2019 (HealthDay News) — The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products.
Vertical Integration Has Little Impact on Quality Measures
THURSDAY, Feb. 21, 2019 (HealthDay News) — Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.
New Kaiser Permanente Medical School Plans to Waive Tuition